Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Utility of an improved model of amyloid-beta (Aß1?42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease.

McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, Ryan TM, Masters CL, Barnham KJ, Bush AI, Cherny RA. Utility of an improved model of amyloid-beta (Aß1?42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Mol Neurodegener. 2012 Nov 21; 7:57.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.